• Type:

Monitoring gene instability in iPSCs

Play

Shin Kawamata, MD, PhD, Director of the R&D Center for Cell Therapy at the FBRI (Kobe, Japan) explains how gene instability can be monitored in iPS cell lines, to provide insight into the safety of clinical iPS-based cell products.

Reviews for Monitoring gene instability in iPSCs

There are currently no reviews for Monitoring gene instability in iPSCs
Scroll to top